Management Forum Logo

Presented by
Management Forum

Variations to Marketing Authorisations Training Course

A two-day event that will provide an invaluable overview of the EU system for variations, with practical advice on the preparation and submission of variation applications using the various European procedures.

★★★★★ "Excellent webinar! [Speaker is] engaging and friendly."

7-8 Jul 2022 + 1 more date

Need help?  Enrol now

  • Format: Live online
  • CPD: 12 hours for your records
  • Certificate of completion

Course overview

It is a key post-marketing responsibility of the marketing authorisation holder (MAH) to keep dossiers up to date, and changes must be submitted as variations to the appropriate regulatory authority.

This interactive event will provide an invaluable overview of the EU system for variations, with practical advice on the preparation and submission of variation applications using the various European procedures. The course will cover the latest variation regulations and offer guidance from an industry expert on how to optimise your regulatory procedures to help achieve faster approval. The programme will include filing tips and strategies with information and advice on creating a global dossier and implementation periods.

Practical sessions throughout the two days will provide an opportunity to discuss different scenarios and strategies with other participants.

Benefits of attending:

  • Gain an overview of the EU system for variations
  • Assess how pharma companies are working in this evolving regulatory environment
  • Profit from practical advice on the preparation and submission of variation applications
  • Understand the impact of Module 3 on your variations dossier
  • Discuss filing tips and strategies to help achieve faster approval

Who should attend?

This course will be particularly relevant for those working in registration and regulatory affairs. It will also be of interest to anyone with an involvement in the variations process including QA, clinical safety and pharmacovigilance personnel.

Enrol now

The Variations to Marketing Authorisations course will cover:

Basis of EU Regulations 1234/2008 and 712/2012

  • Classification in accordance with the legislation
  • Understand the differences between type lA, type IB and type ll variations
  • Clarify foreseen and unforeseen variations

Special topics in variations

  • Handling active ingredient master files as variations
  • Submission of new clinical data

Practical session: Analysing and classifying the different changes

Grouping and work-sharing

  • Understanding when grouping is appropriate
  • Clarifying what types of variations may be grouped
  • Guidance on assembling a grouped submission
  • Understanding when work-sharing is appropriate

Understanding Module 3

  • The dossier impact on variations
  • QbD
  • CQA pyramids

Practical session: Understanding reviewers

Filing strategy

  • Creating a global dossier (gold/silver/ bronze versions)
  • Understanding implementation and grace periods
  • Fixed and rolling implementation strategy

Practical session: Plan the timelines/project management of a variation submission

Other procedures

  • Article 5
  • Urgent safety restrictions
  • Understanding when to use extension applications

Submission planning

  • Identify and understand strategic considerations

Data requirements for type II variations

  • Learn how to identify and support a type II change

Practical session: Data requirements for more complex changes

Variations through national procedures and differences from centralised procedure

  • Understand the procedures
  • Languages and translations
  • Explore the linguistic review process

Mutual recognition and decentralised procedures for variations

  • Understand the procedures and responsibilities of the MAH, RMS and CMS
  • Learn how to efficiently plan for and run an MR variation procedure

Practical session: A variation to an example MRP authorised product including planning timelines and impact of referrals

Advanced compliance

  • Creating your own compliance requirements
  • SUPAC guidance

Enrol now

Marloes van der Geer

Marloes van der Geer works as senior regulatory affairs scientist at Qdossier. Marloes holds a master in Life Sciences (Drug Innovation) from the University of Utrecht, the Netherlands. For nine years she held several positions at Hoffmann-la Roche in Switzerland, including the role of regulatory intelligence manager and regulatory policy lead for the EMEA region. Marloes has been actively involved in several industry associations like EFPIA and IFPMA. Also, she contributed to the ongoing IMI PREFER project in Europe, focused on the generation and use of patient preference data. In 2019, Marloes joined Qdossier. Marloes’ areas of expertise are: eCTD, lean authoring, publishing, biopharmaceuticals (incl. biosimilars), clinical development, regulatory convergence & harmonization and facilitated registration pathways (incl. orphan drugs), local RA activities (e.g. product information management).

More details

Book Variations to Marketing Authorisations Live online training

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

7-8 Jul 2022

Live online

09:00-17:00 UK (London) (UTC+01)
10:00-18:00 Paris (UTC+02)
04:00-12:00 New York (UTC-04)
Course code 11613

  • GBP 1,099 1,299
  • EUR 1,579 1,859
  • USD 1,786 2,098

Until 02 Jun

View basket 

13-14 Oct 2022

Live online

Course code 11721

  • GBP 1,099 1,299
  • EUR 1,579 1,859
  • USD 1,786 2,098

Until 08 Sep

View basket 

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price.

Reviews of IPI's Variations to Marketing Authorisations training course

Excellent webinar! [Speaker is] engaging and friendly.

Apr 13 2021

Abhijit Nair
Regulatory Affairs Officer, Consilient health

Apr 13 2021

It was very interesting and informative.

Dubravka Božičević
Senior Advisor for Validation of Applications, Cratian Agency for medicinal products and medical devices - HALMED

Oct 8 2020

Excellent, clear and interactive

Mohit Pandey
Morningside Healthcare Limited

Oct 8 2020

Andrew is a good speaker and managed to keep our attention during these two days despite the fact that it was a webinar.

Chloë Braud
International Regulatory Affairs Pharmacist, Guerbet

United Kingdom

  • 3M Healthcare Ltd
  • Abbott Laboratories Ltd
  • Allergan UK Limited
  • Allergy Therapeutics Ltd
  • Alliance Pharmaceuticals Ltd
  • Almac Group
  • Archimedes Pharma Ltd
  • Archimedes Pharma UK Limited
  • Avon Automotive plc
  • Bayer Healthcare
  • BlueReg Pharma Consulting
  • BOC Ltd (part of the Linde Group)
  • Boehringer Ingelheim Ltd
  • Bristows LLP
  • Britannia Pharmaceuticals Ltd
  • Chemidex Pharma Ltd
  • Chiesi Limited
  • Co-Operative Pharmacy
  • Consilient health
  • Cross Vetpharm Group UK LTD
  • Cyton Biosciences Ltd
  • Dechra Ltd
  • E.C. De Witt & Company Limited
  • Eli Lilly & Co Ltd
  • Fresenius Kabi Ltd
  • Fresenius Kabi UK Ltd
  • Galderma (UK) Limited
  • Galen Ltd
  • Gilead Sciences International Ltd
  • GlaxoSmithKline
  • Ipsen Biopharm Ltd
  • Janssen-Cilag Ltd
  • JensonR+ Ltd
  • Karib Kemi Pharm Ltd
  • Lundbeck Limited
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Mentholatum Co Ltd
  • Milpharm Ltd/Aurobindo Pharma Limited
  • Morningside Healthcare Limited
  • Mylan
  • NDA Regulatory Science Ltd
  • Novartis Pharmaceuticals UK Ltd
  • Pierre Fabre Ltd
  • Procter & Gamble Technical Centres Ltd
  • Ranbaxy Laboratories Ltd
  • Reckitt Benckiser Healthcare (UK) Ltd
  • Roche Products Ltd
  • Rosemont Pharmaceuticals Limited
  • S A Consultancy Ltd
  • Sanofi Pasteur MSD Ltd
  • Shire Pharmaceutical Ltd
  • Sinclair IS Pharmaceuticals Ltd
  • Teva Pharmaceuticals Europe B.V.
  • Teva UK Ltd
  • Torbay Pharmaceuticals
  • UCB Celltech
  • Waymade Plc
  • Winthrop Pharmaceuticals UK Ltd
  • Wrafton Laboratories Ltd, t/a Perrigo


  • Janssen Pharmaceutica NV
  • PHARA Plus Life Science Services BVBA


  • Galderma International
  • Guerbet
  • Sanofi Pasteur MSD


  • Abbott Healthcare Products BV
  • Intervet Nederland bv
  • Leyden Delta bv


  • Novartis International AG
  • Novartis Vaccines & Diagnostics AG
  • ObsEva


  • Cratian Agency for medicinal products and medical devices - HALMED
  • Novartis Hrvatska doo

Czech Republic

  • Zentiva Group AS
  • Zentiva ks


  • Irish Patents Office
  • Labopharm Europe Ltd


  • Blau Pharmaceutical Services
  • Perrigo Israel Pharmaceuticals Ltd


  • EVER Valinject GmbH


  • Atnahs Pharma Nordics


  • Life Molecular Imaging


  • SIFI S.p.A.


  • APL Swift Services (Malta) Ltd


  • Bluepharma - Indústria Farmacêutica, SA - VAT PT505282801


  • Casen Recordati SL


  • Fresenius Kabi AB

Enrol now

Run Variations to Marketing Authorisations Live online for your team

2 days

Typical duration

Pricing from:

  • GBP 800
  • Per attendee
  • Course tailored to your requirements
  • At your choice of location, or online


We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training expert Aleksandra Beer to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra BEER
Training expert

+44 (0)20 7749 4749